Radioprotection by combination of DNA binding antioxidants & aminothiol radical scavengers

Lead researcher

Dr Pavel Lobachevsky, Prof Roger Martin, Dr Olga Martin

Peter MacCallum Cancer Centre

Years funded

This project studies drugs that are able to prevent damage of normal tissues in cancer radiotherapy patients and may lead to the substantial improvement of the treatment outcome in patients subjected to radiation therapy of tumour.

Lay Report - Final

Exploring the potential of the combination of old and new radioprotecting drugs to reduce normal tissue damage in cancer radiotherapy patients

Funding Body

Cancer Council Research Grant


$100,000 per annum